Literature DB >> 11375457

Withdrawing cardiovascular medications at a syncope clinic.

K Alsop1, M Mac Mahon.   

Abstract

It is widely assumed in clinical practice that drug treatment associated with hypotension can result in falls and syncope, but there is actually very little evidence to support this. Therefore the data in all patients whose cardiovascular medications were stopped at a falls/syncope clinic were analysed to see if their symptoms were altered and if renewal of these medications was necessary at subsequent visits. Of 338 consecutive referrals, cardiovascular medications had been stopped in 65 (19%). At follow up 78% reported improvement in their original presenting symptoms and renewal of medication was not necessary in 77% off antianginals, 69% off antihypertensives, and 36% off antiarrhythmics. It was concluded that adjusting cardiovascular medications could help in the management of falls and syncope and may obviate the need for other treatment. These medications can be stopped in select patients if there is regular monitoring and this should reduce unwanted side effects and costs of these drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375457      PMCID: PMC1742079          DOI: 10.1136/pmj.77.908.403

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  19 in total

1.  Causes and correlates of recurrent falls in ambulatory frail elderly.

Authors:  L A Lipsitz; P V Jonsson; M M Kelley; J S Koestner
Journal:  J Gerontol       Date:  1991-07

Review 2.  Antihypertensive therapy. To stop or not to stop?

Authors:  R E Schmieder; J K Rockstroh; F H Messerli
Journal:  JAMA       Date:  1991-03-27       Impact factor: 56.272

3.  Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group.

Authors:  F Gueyffier; C Bulpitt; J P Boissel; E Schron; T Ekbom; R Fagard; E Casiglia; K Kerlikowske; J Coope
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

4.  Medications and diagnoses in relation to falls in a long-term care facility.

Authors:  E Granek; S P Baker; H Abbey; E Robinson; A H Myers; J S Samkoff; L E Klein
Journal:  J Am Geriatr Soc       Date:  1987-06       Impact factor: 5.562

5.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Authors:  B Dahlöf; L H Lindholm; L Hansson; B Scherstén; T Ekbom; P O Wester
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

6.  Syncope and presyncope associated with probable adverse drug reactions.

Authors:  J T Hanlon; M Linzer; J P MacMillan; I K Lewis; A A Felder
Journal:  Arch Intern Med       Date:  1990-11

7.  Drug-related syncope.

Authors:  E Davidson; J Fuchs; Z Rotenberg; I Weinberger; J Agmon
Journal:  Clin Cardiol       Date:  1989-10       Impact factor: 2.882

8.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

9.  Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope.

Authors:  T C Gibson; M R Heitzman
Journal:  Am J Cardiol       Date:  1984-04-01       Impact factor: 2.778

10.  Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting enzyme inhibitors in essential hypertensives.

Authors:  Y Takata; T Yoshizumi; Y Ito; M Ueno; A Tsukashima; M Iwase; K Kobayashi; M Fujishima
Journal:  Am Heart J       Date:  1992-12       Impact factor: 4.749

View more
  3 in total

Review 1.  A benefit-risk assessment of agents used in the secondary prevention of stroke.

Authors:  Ronald S MacWalter; Colin P Shirley
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Cost effectiveness of withdrawal of fall-risk-increasing drugs in geriatric outpatients.

Authors:  Nathalie van der Velde; Willen Jan Meerding; Caspar W Looman; Huibert A P Pols; Tischa J M van der Cammen
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 3.  The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.

Authors:  Amy T Page; Rhonda M Clifford; Kathleen Potter; Darren Schwartz; Christopher D Etherton-Beer
Journal:  Br J Clin Pharmacol       Date:  2016-06-13       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.